The search for more effective treatments and more ethical research methods has just taken an important step. A team of scientists from the Swiss federal laboratory, Empa, developed an AI-assisted computer model capable of simulating how nanoparticles behave within the organism.
The tool digitally reproduces the body of a mouse and allows predicting the distribution of different nanomaterials in key organs such as the liver, kidneys, lungs, and spleen. This way, researchers can analyze potential results without immediately resorting to laboratory animals.
Moreover, this advancement represents an innovative alternative to optimize scientific resources and reduce the impact associated with traditional experimentation. Therefore, the proposal sparks interest in both the medical and environmental fields.
Nanoparticles with the potential to transform treatments
Nanoparticles are microscopic structures so small that hundreds of them could align within the thickness of a human hair. Thanks to their characteristics, they can act as vehicles capable of transporting drugs to specific areas of the body.
Consequently, they have become one of the most promising tools in modern medicine. Their ability to precisely target treatments could improve therapeutic efficacy and reduce side effects.
Particularly relevant is their potential to treat neurological diseases. Some nanoparticles can cross the blood-brain barrier, a natural protection that makes it difficult for many drugs to enter the brain. This feature opens new possibilities for addressing brain tumors and other complex pathologies.
However, there are thousands of possible combinations of size, shape, surface charge, and coating. Due to this, determining the behavior of each variant required until now extensive experimental trials.
How the new AI-based tool works
The model developed by Empa was trained using information from 18 previous studies conducted with mice. From these data, the system uses machine learning algorithms to calculate the likely fate of each nanoparticle within the organism.
This way, researchers can virtually evaluate numerous candidates before manufacturing them or subjecting them to biological tests. As a result, time, costs, and the need for animal experimentation are reduced.
Additionally, the tool allows for quicker identification of which formulations have the best chances of success. However, specialists acknowledge that expanding the database will be essential to improve the accuracy of future predictions.
An initiative with scientific and environmental benefits
The use of virtual models offers advantages that transcend the medical field. Firstly, it helps to reduce the number of animals used in research, a goal promoted by numerous international scientific organizations.
Furthermore, it reduces the consumption of materials, reagents, and energy resources associated with conventional trials. This promotes a more efficient scientific practice with less environmental impact.
On the other hand, the ability to discard unpromising options before manufacturing avoids waste and optimizes innovation processes. Thus, artificial intelligence becomes an ally for developing more sustainable technologies.
The next challenge: creating a virtual human organism
Following the results obtained, the team is already working on a new stage of the project. The goal is to adapt the system to simulate the human body through a strategy that allows transferring the knowledge obtained in animal models.
Unlike the current version, a human model could include more complex and sensitive organs, among them the brain. This would allow for more precise studies on whether certain nanoparticles can cross biological barriers and reach specific tissues.
As research progresses, this combination of artificial intelligence and nanotechnology is emerging as a tool capable of accelerating the development of innovative treatments while promoting a more ethical and environmentally respectful science.
